On the horizon in heart failure : The Lancet
Links shared publicly online about this topic.
- 59total visits
On the horizon in heart failure : The Lancet
View full resource at thelancet.com
Tags: Heart, Heart Disease, Heart Failure, Healthy Living
Most Recently Shared on August 20, 2011 at 8:30 am By:
Editorial: On the horizon in heart failure (The Lancet) http://t.co/Fm5tlMy - #health
Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial : The Lancet
thelancet.com — “Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. By - Prof Roberto Bolli MD, Atul R Chugh MD, Domenico D'Amario MD, John H Lough...” View full resource at thelancet.com
Most Recently Shared on November 14, 2011 at 2:10 pm By:
First-in-man study shows cardiac stem cells show promise for treating heart failure caused by ischaemic heart disease http://t.co/jwklyA2h
In search of new therapeutic targets and strategies f... [Lancet. 2011] - PubMed - NCBI
ncbi.nlm.nih.gov — “PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on September 15, 2011 at 11:10 pm By:
Tom Heston, MD Family Medicine Doctor, Physician, and Doctor
In search of new therapeutic targets and strategies for heart failure: recent advances ... http://t.co/CbRbj4a2 #medicine
Greater Lifetime Risk Of Developing COPD Than Heart Failure And Many Common Cancers
medicalnewstoday.com — “According to the first comprehensive estimate of lifetime risk for chronic obstructive pulmonary disease (COPD) published in a special European Respiratory Society issue of The Lancet, one” View full resource at medicalnewstoday.com
Most Recently Shared on September 9, 2011 at 3:05 pm By:
Greater Lifetime Risk Of Developing COPD Than Heart Failure And Many Common Cancers http://mnt.to/3Zyb #healthnews
Can Omecamtiv Mecarbil Help Heart Failure Patients? Too Early To Tell - QualityPoint Technologies
qualitypointtech.net — “An article published in the Lancet revealed results of two clinical trials of omecamtiv mecarbil, a drug that according to researchers could one-day benefit heart failure patients by assisting the heart to contract more easily. Omecamtiv mecarbil, developed in San Francisco, activates a protein that increases the contraction of the heart muscle. First clinical trials indicate that it could help patients with stable systolic heart failure. Heart failure is defined as the inability of the heart to” View full resource at qualitypointtech.net
Most Recently Shared on August 22, 2011 at 12:45 am By:
Can Omecamtiv Mecarbil Help Heart Failure Patients? Too Early To Tell: An article published in the Lancet revealed... http://t.co/rgzVcBM
Can Omecamtiv Mecarbil Help Heart Failure Patients? Too Early To Tell
medicalnewstoday.com — “An article published in the Lancet revealed results of two clinical trials of omecamtiv mecarbil, a drug that according to researchers could one-day benefit heart failure patients by assist” View full resource at medicalnewstoday.com
Most Recently Shared on August 21, 2011 at 7:05 am By:
MNT Cardiovascular Health News
Can Omecamtiv Mecarbil Help Heart Failure Patients? Too Early To Tell http://mnt.to/3Z69 #cardiovascular
Implantable cardioverter defibrillators and cardiac resynchronisation therapy : The Lancet
thelancet.com — “Implantable cardioverter defibrillators and cardiac resynchronisation therapy. By - Dr Johannes Holzmeister MD, Prof Christophe Leclercq MD” View full resource at thelancet.com
Most Recently Shared on August 19, 2011 at 10:51 pm By:
M Auron MD Pediatrician, Internist, Physician, and Doctor
Medical therapy for chronic heart failure - http://t.co/lhKSvLg and ICD/CRT - http://t.co/kZmZqsJ
TheLancet.com
thelancet.com — “The Lancet is the world's leading general medical journal and specialty journals in Oncology, Neurology and Infectious Diseases. Available online first. Free registration.” View full resource at thelancet.com
Most Recently Shared on August 19, 2011 at 12:49 pm By:
Calling all cardiologists, this week's Lancet is a heart failure themed issue http://t.co/Lsy8THO
Glycaemic control and incidence of heart failure in 20?985 patients with type 1 diabetes: an observational study : The Lancet
thelancet.com — “Glycaemic control and incidence of heart failure in 20?985 patients with type 1 diabetes: an observational study. By - Dr Marcus Lind MD, Ioannis Bounias MD, Marita Olsson PhD, Soffia Gudbjörnsdott...” View full resource at thelancet.com
Most Recently Shared on July 18, 2011 at 7:26 pm By:
Glycaemic control & incidence of heart failure in 20,985 patients with T1D diabetes: observational study (The Lancet) http://bit.ly/jQ4O63?
Symposier - Wireless Monitor Reduces Heart Failure Hospitalizations
symposier.com — “Uploaded and shared in Youtube by: osumedicalcenter --" http://bit.ly/eSojuD With millions of people hospitalized each year due to heart failure, results from a pivotal clinical trial show that an implantable pulmonary artery pressure device in patients with moderate heart failure results in significant reductions in hospitalizations and re-admissions for those patients. The study, published Feb. 10 in the Lancet, represents the first major breakthrough in heart failure management in the past de” View full resource at symposier.com
Most Recently Shared on March 4, 2011 at 10:51 pm By:
Symposier Cardiology Cardiology and Health Business
Wireless Monitor Reduces Heart Failure Hospitalizations, first major breakthrough in HF management in the past decade. http://bit.ly/hnushE
Lancet: Telemonitoring reduces hospitalizations for HF patients
cmio.net — “Results from a clinical trial have produced the first positive, randomized findings for an implantable hemodynamic monitoring device in patients with moderately symptomatic heart failure where the addition of information about pulmonary artery pressure to clinical signs and symptoms allowed for improved heart failure management and led to a reduction in heart failure-related hospitalizations, according to the CHAMPION study published online Feb. 10 in the Lancet.” View full resource at cmio.net
Most Recently Shared on February 15, 2011 at 3:58 pm By:
Luis Saldana Emergency Physician, Physician, and Doctor
Lancet: Telemonitoring reduces hospitalizations for HF patients http://bit.ly/hngJZl
British Heart Foundation - Mending Broken Hearts
bhf.org.uk — “Our Mending Broken Hearts Appeal aims to raise 50 million to fund the research that could one day help us to literally 'mend broken hearts'.” View full resource at bhf.org.uk
Most Recently Shared on February 1, 2011 at 8:37 am By:
RT @Kevin_Fong Please look @ the @TheBHF incredibly important "mending broken hearts" site http://bit.ly/HOPEisComing #horizon #HopeisComing
Family Medicine News & Articles - MDLinx - Heart Failure on #MDlinx
mdlinx.com — “Family Medicine News & Articles - MDLinx - Heart Failure on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on September 23, 2010 at 5:33 am By:
Sandeep Pulim MD Health Communicator, Physician, and Doctor
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study: The Lancet http://bit.ly/cANh2W #GM #mdlinx
Cardiology News & Articles - MDLinx - Heart Failure on #MDlinx
mdlinx.com — “Cardiology News & Articles - MDLinx - Heart Failure on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on September 22, 2010 at 5:40 am By:
Sandeep Pulim MD Health Communicator, Physician, and Doctor
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study: The Lancet http://bit.ly/bL2ukq #cardiology
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study : The Lancet
thelancet.com — “Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. By - Prof Karl Swedberg MD, Prof Michel Komajda MD, Prof Michael B'hm MD, Prof Jeffrey S Borer MD, P...” View full resource at thelancet.com
Most Recently Shared on September 10, 2010 at 3:32 pm By:
M Auron MD Pediatrician, Internist, Physician, and Doctor
Ivabradine is a negative cronotropic drug - shown beneficial effect in CHF - http://bit.ly/cXcHsQ
Advertisement
